Intended for healthcare professionals

News

Sixty seconds on . . . baloxavir

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4531 (Published 26 October 2018) Cite this as: BMJ 2018;363:k4531
  1. Nigel Hawkes
  1. London, UK

I’m guessing it’s a drug?

Quite right. Baloxavir marboxil (Xofluza) is a new drug for treating flu, approved by the US Food and Drug Administration in double quick time and ready for this year’s US flu season.

Is it any good?

Actually, no better than oseltamivir (Tamiflu) in trials reported in the New England Journal of Medicine in September.1 Compared with a placebo, it …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription